Puma Biotechnology, Inc. (PBYI)
5.73
+0.14
(+2.50%)
USD |
NASDAQ |
Dec 11, 16:00
5.74
+0.01
(+0.17%)
After-Hours: 20:00
Puma Biotechnology Cash from Investing (Quarterly): 0.506M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Nephros, Inc. | 0.00 |
| Sensus Healthcare, Inc. | -0.004M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Vanda Pharmaceuticals, Inc. | 21.36M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.689M |
| Cash from Financing (Quarterly) | -11.33M |
| Free Cash Flow | 42.87M |
| Free Cash Flow Per Share (Quarterly) | 0.1897 |
| Free Cash Flow to Equity (Quarterly) | 17.84M |
| Free Cash Flow to Firm (Quarterly) | 11.09M |
| Free Cash Flow Yield | 14.93% |